The Emergence of COVID-19 to Augment the Breathing Machines Market Growth

A breathing machine, also known as a mechanical ventilator, is used to assist the function of the lungs. Breathing machines provide mechanical ventilation by moving breathable air into and out of the lungs. The main function of a mechanical ventilator is to prevent or reduce respiratory difficulties and to help relieve the patient suffering from respiratory disorders. Breathing machines are widely used for patients suffering from breathing disorders such as asthma, chronic obstructive pulmonary disease (COPD), emphysema, bronchial pneumonia, respiratory failure, cardiorespiratory failure, etc. Growth of the breathing machines market is mainly driven by the emergence of COVID-19.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2032

Mechanical ventilation is an arsenal for COVID-19 (an infectious disease caused by the novel coronavirus) patients with the most severe lung symptoms. The novel coronavirus can produce fluid and mucus in the lungs that block the oxygenation of lung tissue. A breathing machine can help the patient breathe until their immune system and treatment can clear the infection and proper lung function is restored. According to the World Health Organization (WHO), around 32 million people will require oxygen therapy in the forthcoming months. For instance, in March 2020, Virgin Orbit planned to mass-produce new medical breathing device to help fight coronavirus pandemic, after receiving the necessary approvals from the FDA.

Moreover, in March 2021, Australian engineers developed a low-cost and accessible oxygen concentrator that will help less-developed countries treat patients with breathing difficulties associated with COVID-19 and other respiratory diseases. The breathing machines market is witnessing robust growth due to increasing prevalence of respiratory diseases, such as asthma and COPD worldwide. COPD is the third leading cause of death by disease in the United States. According to the American Lung Association, more than 16.4 million Americans have been diagnosed with COPD, but millions more may have the disease without even knowing it.

According to WHO, worldwide, the four major potentially fatal respiratory diseases, such as tuberculosis, lung cancer, pneumonia, and COPD will account for around one in five deaths by 2030. Thus, with the increasing prevalence of respiratory diseases, the demand for breathing machine is also increasing. For instance, in April 2019, InnAccel launched SAANS, the infrastructure-independent, portable, neonatal CPAP system to provide breathing support to critically ill neonates with respiratory distress syndrome in resource-poor settings and during transportation.

However, drawbacks and complications associated with breathing machines, such as sleeping discomfort, damage to vocal cords, throat discomfort, pneumonia or infection, collapsed lung, lung damage, etc., are major factors restraining the breathing machines growth.

Buy This Research Study Report With Flat US $1000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2032

Major Key Players Are: BD, Drager Medical, Fisher & Paykel, GE Healthcare, Invacare, Maque, Medtronic, OMRON, Philips Healthcare, Teijin Pharma Resmed, and Weinmann.

Contact Us

Name: Mr. Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Check Here Latest Insights: https://www.coherentmarketinsights.com/latest-insights

This release was published on openPR.